common side effects of glp-1 drugs Do The Benefits OutWeigh the Negatives? Adverse effects of GLP-1 class
Description
Eli Lillys Zepbound produced average weight loss of 22.5 percent in trials, and its next-generation injection, retatrutide, pushed that even higher
Here are some stats: Pancreatitis is seen in about 0.2% of people in studies, which is similar to people not taking the drug, but its still a known risk so its taken seriously
Neuroimaging studies indicate decreased activity in reward regions when exposed to food signals, implying an alteration in hedonic eating behaviour (Devoto et al
GLP-1 weight loss medications such as semaglutide (Wegovy) and tirzepatide (Zepbound) may be effective for menopausal weight gain
